Doripenem Injection 250 mg – Premium Sterile Antibiotic Solution for London, UK
Manufactured with Precision. Trusted for Pharmaceutical Quality.
Ernest Oncology offers Doripenem Injection 250 mg, a sterile injectable antibiotic formulated with advanced pharmaceutical technology in India. Produced in WHO-GMP certified manufacturing facilities, every vial is carefully developed under controlled aseptic conditions to maintain exceptional purity, sterility, stability, and consistent pharmaceutical performance.
Designed for intravenous (IV) administration, the formulation reflects internationally accepted manufacturing practices and rigorous quality standards.
London Pharmaceutical Market Information
London remains one of Europe's most advanced healthcare destinations, supported by world-renowned hospitals, specialist medical centres, and modern healthcare infrastructure. As healthcare systems continue to evolve, there is increasing reliance on sterile injectable antibiotics manufactured according to globally recognized pharmaceutical standards.
Indian pharmaceutical manufacturers have earned international confidence by consistently producing quality medicines supported by innovation, scientific expertise, and reliable manufacturing systems.
Why Indian Pharmaceutical Manufacturing Stands Out
India continues to play an important role in supplying pharmaceutical products to healthcare systems worldwide through quality-driven manufacturing and continuous innovation.
Manufacturing Highlights
- WHO-GMP approved production facilities
- Advanced aseptic manufacturing technology
- International pharmaceutical standards
- High-quality active ingredients
- Consistent manufacturing processes
- Modern quality assurance laboratories
- Export-standard packaging
- Scientifically validated production
- Continuous product development
- Strong global pharmaceutical reputation
Key Features
- Doripenem sterile injectable formulation
- Carbapenem class antibiotic
- Sterile powder for intravenous use
- WHO-GMP certified manufacturing
- High pharmaceutical purity
- Stable pharmaceutical formulation
- Batch-tested quality
- Advanced aseptic production
- Export-quality packaging
- Manufactured using international quality standards
Product Description
Doripenem Injection 250 mg contains Doripenem, a carbapenem antibiotic formulated as a sterile powder for intravenous administration. The formulation is produced using modern pharmaceutical technology designed to preserve sterility, maintain formulation stability, and ensure consistent batch quality.
Each production batch undergoes comprehensive quality evaluation before release.Mechanism of Action
Doripenem helps eliminate susceptible bacteria by interfering with bacterial cell wall formation.
It binds to specific bacterial proteins responsible for cell wall synthesis, weakening bacterial structure and ultimately causing bacterial destruction. This mechanism supports effective antibacterial activity against susceptible organisms.
Recommended Dosage
The appropriate dosage should always be determined by a qualified healthcare professional.
Treatment depends upon:
- Nature of bacterial infection
- Severity of illness
- Patient age
- Body weight
- Kidney function
- Individual clinical assessment
The medicine should only be administered under professional supervision.
Possible Side Effects
Some individuals may experience temporary side effects during treatment.
Possible reactions include:
- Headache
- Nausea
- Vomiting
- Diarrhea
- Injection site irritation
- Skin rash
- Fever
- Dizziness
- Allergic reactions
- Temporary liver function changes
Consult a healthcare professional if symptoms become severe or persistent.
Safety Information
- Prescription-only medicine.
- For intravenous administration by trained healthcare professionals.
- Inform your healthcare provider about previous allergies to antibiotics.
- Complete the prescribed treatment schedule.
- Do not use after the expiry date.
- Store safely away from children.
Storage Information
- Store below 25°C
- Protect from moisture
- Avoid direct sunlight
- Keep in original packaging
- Do not freeze
- Use before the expiry date
Quality Assurance
Ernest Oncology follows comprehensive pharmaceutical quality systems to ensure every vial meets internationally recognized manufacturing standards.
Our Quality Commitment
- WHO-GMP certified manufacturing facilities
- Sterility validation throughout production
- Batch-wise laboratory testing
- Raw material quality verification
- Stability monitoring
- Packaging inspection
- Complete product traceability
- Continuous quality improvement
Documentation
The following documents are generally available:
- Commercial Invoice
- Packing List
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- Product Specification Sheet
- Certificate of Pharmaceutical Product (CPP)* (where applicable)
- Batch Manufacturing Record* (where applicable)
- Shipping Documents (AWB / Bill of Lading)
Partner with Ernest Oncology
At Ernest Oncology, our focus extends beyond manufacturing medicines—we are committed to advancing healthcare through innovation, precision, and uncompromising pharmaceutical quality. Every formulation reflects our dedication to scientific excellence, patient safety, and internationally recognized manufacturing practices that contribute to better healthcare worldwide.
Frequently Asked Questions (FAQs)
1. What is Doripenem Injection 250 mg?
Doripenem Injection 250 mg is a sterile carbapenem antibiotic formulated for intravenous administration under medical supervision.
2. How is Doripenem Injection administered?
It is administered by intravenous (IV) infusion by qualified healthcare professionals.
3. What type of antibiotic is Doripenem?
Doripenem belongs to the carbapenem class of broad-spectrum antibiotics.
4. How should Doripenem Injection 250 mg be stored?
Store below 25°C, protected from moisture and direct sunlight, inside the original packaging.
5. Is Doripenem Injection available without a prescription?
No. Doripenem Injection 250 mg is a prescription-only medicine and should only be used under professional medical supervision.
📞 Ernest Oncology — Committed to Better Healthcare
A Specialized Healthcare Division of Ernest Pharmaceutical Pvt. Ltd.
Explore Our Official Websites
- www.oncologymedicinesupplier.com
- www.ernestpharmaceuticals.com
- www.ernestvision.com
- www.ernestimpex.com
📧 Contact Us
Email: exports@ernestpharmaceuticals.com
Our Purpose
- Advancing Oncology Care
- Manufacturing Trusted Pharmaceutical Products
- Innovation Through Science
- Delivering Healthcare Excellence Worldwide
+91 93599 02383
Medical Disclaimer
Description
Ernest Oncology manufactures Doripenem Injection 250 mg in India under WHO-GMP certified facilities. High-quality sterile carbapenem antibiotic injection developed with advanced pharmaceutical standards for healthcare in London, UK.
- Doripenem Injection 250 mg
- Doripenem Injection 500 mg
- Doripenem for Injection 250 mg
- Doripenem for Injection 500 mg
- Doripenem Sterile Powder for Injection 250 mg
- Doripenem Sterile Powder for Injection 500 mg
- Doripenem IV Injection 250 mg
Written By
Chaitali H.
B. Pharma
